share price, page-17

To consider from conference call

CEO - predicts it will be reject in June
I think the COO was the one that stated they can't answer some of the EMA questions - would suggest not good for any appeal (can't explain why the difference in the groups - adult v child v adolescent)
Going to appeal may or may not suceed
If it fails they are literally back to doing completely new P3 trials (will need to capital raise)
FDA application is now on hold and failed its end point anyway so this will possibly end that
Has around 50 mill in cash but has been burning 10 mill a 1/4. Even if they hit the brakes now slowing down the cashburn will take time. How long before they need more cash??